​

Ginkgo Bioworks Stock (NYSE:DNA)

ForecastRevenueOwnershipFinancialsChartTranscripts
Ginkgo Bioworks by TradingView

Previous Close

$7.17

52W Range

$5.00 - $17.58

50D Avg

$8.51

200D Avg

$10.38

Market Cap

$455.76M

Avg Vol (3M)

$1.09M

Beta

1.59

Div Yield

-

DNA Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

834

IPO Date

Apr 19, 2021

Website

DNA Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Service$37.41M$53.07M$78.97M
Product--$28.95M

Fiscal year ends in Dec 25 | Currency in USD

DNA Financial Summary

Dec 25Dec 24Dec 23
Revenue$170.16M$227.04M$251.46M
Operating Income$-315.28M$-559.76M$-864.41M
Net Income$-312.76M$-547.03M$-892.87M
EBITDA$-315.28M$-484.39M$-821.29M
Basic EPS$-5.64$-10.54$-18.37
Diluted EPS$-5.64$-10.54$-18.40

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 27, 26 | 4:30 PM
Q3 25Nov 06, 25 | 4:30 PM
Q2 25Aug 08, 25 | 5:30 PM

Peer Comparison

TickerCompany
IOVAIovance Biotherapeutics, Inc.
VIRVir Biotechnology, Inc.
VALNValneva SE
MBXMBX Biosciences, Inc. Common Stock
MGTXMeiraGTx Holdings plc
AVBPArriVent BioPharma, Inc. Common Stock
REPLReplimune Group, Inc.
ARVNArvinas, Inc.
MRVIMaravai LifeSciences Holdings, Inc.